Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Sarcoma, Ewing × thymoglobulin × Sarcoma × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Lymphoma, Non-Hodgkin 5 Leukemia, Myelomonocytic, Juvenile 5 Leukemia, Myeloid, Acute 5 Myelodysplastic Syndromes 3 Lymphoma, Mantle-Cell 3 Lymphoma, Large-Cell, Immunoblastic 3 Lymphoma, Large B-Cell, Diffuse 3 Lymphoma, Follicular 3 Lymphoma, B-Cell, Marginal Zone 3 Leukemia, Myelomonocytic, Chronic 3 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3 Leukemia, Lymphocytic, Chronic, B-Cell 3 Burkitt Lymphoma 3 Waldenstrom Macroglobulinemia 2 Sezary Syndrome 2 Sarcoma, Myeloid 2 Rhabdomyosarcoma 2 Recurrence 2 Primary Myelofibrosis 2 Pdgfra-Associated Chronic Eosinophilic Leukemia 2 Neuroblastoma 2 Myeloproliferative Disorders 2 Mycosis Fungoides 2 Multiple Myeloma 2 Lymphoma, T-Cell, Cutaneous 2 Lymphoma, Large-Cell, Anaplastic 2 Lymphoma, Extranodal NK-T-Cell 2 Leukemia, Neutrophilic, Chronic 2 Leukemia, Myeloid, Chronic-Phase 2

Interventions

Cyclophosphamide 24 Temozolomide 21 Irinotecan 18 Vincristine 17 Doxorubicin 13 Topotecan 10 Melphalan 10 Etoposide 10 Ifosfamide 8 Busulfan 8 Magnetic Resonance Spectroscopy 7 Granulocyte Colony-Stimulating Factor 7 Filgrastim 6 cabozantinib 5 X-Rays 5 Specimen Handling 5 Sirolimus 5 Drug Therapy 5 regorafenib 4 pegfilgrastim 4 palbociclib 4 liposomal doxorubicin 4 fludarabine phosphate 4 fludarabine 4 Trabectedin 4 Radiotherapy 4 Phantoms, Imaging 4 Nivolumab 4 Gemcitabine 4 FANG vaccine 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02472392 2017-05-09

Ewing/Allo

University of Louisville

Phase 1 Completed

Sarcoma, Ewing

Data powered by HemOnc (CC BY 4.0) Colophon ⚡